Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.
- DOI
- 10.3389/fonc.2025.1526931
- Published
- 2025
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2025.1526931,
title = {Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.},
author = {Justeau G and Chouaid C and Debieuvre D and Audigier-Valette C and Quantin X and Léna H and Bosquet L and Girard N and Schoemaker MJ and Mella M and Pinto Correia B and Rault C and Daumont MJ and Penrod JR and Lee A and Pérol M},
year = {2025},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2025.1526931},
url = {https://doi.org/10.3389/fonc.2025.1526931}
}RIS
TY - JOUR TI - Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis. AU - Justeau G AU - Chouaid C AU - Debieuvre D AU - Audigier-Valette C AU - Quantin X AU - Léna H AU - Bosquet L AU - Girard N AU - Schoemaker MJ AU - Mella M AU - Pinto Correia B AU - Rault C AU - Daumont MJ AU - Penrod JR AU - Lee A AU - Pérol M PY - 2025 JO - Frontiers in oncology DO - 10.3389/fonc.2025.1526931 UR - https://doi.org/10.3389/fonc.2025.1526931 ER -
APA
G, J., C, C., D, D., C, A., X, Q., H, L., L, B., N, G., MJ, S., M, M., B, P. C., C, R., MJ, D., JR, P., A, L., & M, P. (2025). Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1526931
Source records
- pubmed · retrieved 2026-09-27T12:23:59.712Z